These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6720461)

  • 21. Effects of chronic corticosteroid therapy on mineral metabolism and calcium absorption.
    Avioli LV
    Adv Exp Med Biol; 1984; 171():81-9. PubMed ID: 6372405
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucocorticoids and Bone. Proceedings of a symposium. Vienna, Austria, 12 March 1991.
    Br J Rheumatol; 1993 May; 32 Suppl 2():1-48. PubMed ID: 8098644
    [No Abstract]   [Full Text] [Related]  

  • 23. Deflazacort in thrombocytopenia: a comparison with prednisone.
    Mazzucconi MG; Malagnino F; De Laurentis C; Criscuolo D
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):538-42. PubMed ID: 7194867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cortisone-induced osteoporosis: from physiopathogenesis to treatment].
    Peretz A
    Rev Med Brux; 1991 Oct; 12(8):321-8. PubMed ID: 1947526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Alphacalcidol in the treatment of osteopenic syndrome in patients with bronchial asthma].
    Kochetkova EA; Gel'tser BI
    Ter Arkh; 2002; 74(3):32-5. PubMed ID: 11980117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose inhaled steroids in asthmatic children.
    Lipworth BJ; Clark D
    Lancet; 1996 Sep; 348(9030):820; author reply 821. PubMed ID: 8813996
    [No Abstract]   [Full Text] [Related]  

  • 28. Results of long-term treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS; Eriksson S; Lindholm TC
    Ital J Orthop Traumatol; 1984 Jun; 10(2):187-201. PubMed ID: 6432736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral tibial marrow ablation in rats induces a rapid hypercalcemia arising from extratibial bone resorption inhibitable by methylprednisolone or deflazacort.
    Magnuson SK; Booth R; Porter S; Gorski JP
    J Bone Miner Res; 1997 Feb; 12(2):200-9. PubMed ID: 9041051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo effects of 'equipotent' doses of synthetic steroids on lymphocytes and on the pituitary-adrenal system in man.
    Newsome HH; Thomas JM
    Surg Forum; 1977; 28():118-20. PubMed ID: 617391
    [No Abstract]   [Full Text] [Related]  

  • 31. Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients.
    Behan LA; Kelleher G; Hannon MJ; Brady JJ; Rogers B; Tormey W; Smith D; Thompson CJ; McKenna MJ; Agha A
    Eur J Endocrinol; 2014 Jan; 170(1):141-50. PubMed ID: 24123094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
    Benucci M; Dolenti S; Saviola G; Manfredi M
    Recenti Prog Med; 2006 Jan; 97(1):24-7. PubMed ID: 16535926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problems in evaluating dose equivalences of glucocorticoids.
    Köbberling J; Rotenberger J
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):434-6. PubMed ID: 1490770
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in bone histomorphometry and bone mineral during treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS; Nilsson OS; Elmstedt E; Eriksson SA; Lindholm TC; Kyhle BR
    Acta Vitaminol Enzymol; 1981; 3(3):170-6. PubMed ID: 7347489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of the effect of a daily steroid regimen versus a weekly oral pulse steroid regimen on morphological changes, blood sugar, bone mineral density and suprarenal gland activity.
    El-Darouti MA; Mashaly HM; El-Nabarawy E; El-Tawdy AM; Fawzy MM; Salem DS; El-Kaffas KM; El Sayed DA
    J Dermatolog Treat; 2012 Feb; 23(1):4-10. PubMed ID: 20819024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prednisone versus deflazacort in the treatment of autoimmune thrombocytopenic purpura: evaluation of clinical response and immunological modifications.
    Ferrari A; Pasqualetti D; Del Bianco P; Gandolfo GM; Chistolini A; Mazzucconi MG
    Haematologica; 1991; 76(4):342-5. PubMed ID: 1794742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring and management of bone status in patients on chronic glucocorticoid treatment--the Medscheme experience.
    Rothberg AD; Matshidze PK
    S Afr Med J; 2000 Nov; 90(11):1125-9. PubMed ID: 11196035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternate programs of steroid administration for patients on long-term therapy.
    LoDolce D; Clancey J
    J Neurosurg Nurs; 1980 Dec; 12(4):187-94. PubMed ID: 6906357
    [No Abstract]   [Full Text] [Related]  

  • 40. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
    J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.